Pfizer's Upjohn has merged with Mylan to form Viatris Inc. clinical trials

Acquired by Viatris Inc., Nov 16, 2020 · source ↗

The registry lists 434 studies whose lead sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 10, 2023.

Studies

Recruiting first, then most recently updated. Showing 50 of 434. List all 434 → · All Viatris Inc. studies →

• Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)CompletedNCT01279850

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)CompletedNCT01773993

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)CompletedNCT01256593

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)CompletedNCT03342690

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Long Term Use Of Xalacom In Patients Glaucoma Or Ocular HypertensionCompletedNCT01191008

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)CompletedNCT02958527

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Non Interventional Study In Bipolar Disorder And Schizophrenia With ZeldoxCompletedNCT00538629

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Effects of Oral Sildenafil on Mortality in Adults With PAHTerminatedNCT02060487Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical AntipsychoticsCompletedNCT00448630

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)CompletedNCT01302080

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).CompletedNCT00383019Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic NeuralgiaCompletedNCT00424372Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The NewbornCompletedNCT01720524Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Identification of Underlying Conditions in Men Prescribed a PDE5 InhibitorCompletedNCT01150903

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I DisorderTerminatedNCT03768726Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I DisorderTerminatedNCT02075047Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or PlaceboCompletedNCT00351611Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic SubjectsCompletedNCT00312494Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"CompletedNCT00139776Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Ziprasidone And Olanzapine's Outcomes In ManiaTerminatedNCT00329108Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.CompletedNCT00282464Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To ZiprasidoneCompletedNCT00406315Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Safety And Efficacy Of Ziprasidone In Adolescents With SchizophreniaTerminatedNCT00257192Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)CompletedNCT00280566Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)CompletedNCT00265330Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I DepressionCompletedNCT00141271Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031CompletedNCT00174447Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• 8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial HypercholesterolemiaCompletedNCT00739999Phase 1

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial TabletCompletedNCT00917579Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels StudyCompletedNCT00540293Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Bioavailability Study for New Atorvastatin FormulationCompletedNCT00844376Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Adjunctive Ziprasidone in the Treatment of Bipolar I DepressionCompletedNCT00483548Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Treatment of Schizophrenic Patients With ZiprasidoneCompletedNCT00579670

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological SurgeryCompletedNCT00150280Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Safety And Tolerability Of Ziprasidone In Adolescents With SchizophreniaTerminatedNCT00265382Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox CapsuleCompletedNCT01053429

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Study of Celecoxib Bioavailability in Healthy SubjectsCompletedNCT00296127Phase 1

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)CompletedNCT00257166Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeTerminatedNCT00748566Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.CompletedNCT00290901Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic SyndromeTerminatedNCT01113541Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Effect Of Celecoxib On Hip Osteoarthritis (OA) ProgressionTerminatedNCT00163241Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenCompletedNCT00346216Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With AgitationCompletedNCT00723606Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With ArthritisCompletedNCT00141102Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With SchizophreniaCompletedNCT00139737Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)CompletedNCT00373685Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Celebrex Total Knee Arthroplasty StudyTerminatedNCT00359151Phase 4

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In JapanCompletedNCT00141154Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.

• Testing The Effectiveness Of Celecoxib In Patients With Painful Sore ThroatCompletedNCT00402987Phase 3

  Sponsor listed in the registry: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · First submitted before Pfizer's Upjohn has merged with Mylan to form Viatris Inc. became part of Viatris Inc.